Comparison of a Multiple Daily Insulin Injection Regimen (Basal Once-Daily Glargine Plus Mealtime Lispro) and Continuous Subcutaneous Insulin Infusion (Lispro) in Type 1 Diabetes: A randomized open parallel multicenter study

OBJECTIVE: Insulin pump therapy (continuous subcutaneous insulin infusion [CSII]) and multiple daily injections (MDIs) with insulin glargine as basal insulin and mealtime insulin lispro have not been prospectively compared in people naïve to either regimen in a multicenter study. We aimed to help cl...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Bolli, Geremia B., Kerr, David, Thomas, Reena, Torlone, Elisabetta, Sola-Gazagnes, Agnès, Vitacolonna, Ester, Selam, Jean Louis, Home, Philip D.
Format: Artigo
Idioma:Inglês
Publicat: American Diabetes Association 2009
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2699706/
https://ncbi.nlm.nih.gov/pubmed/19389820
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc08-1874
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars